Stay updated on Pembrolizumab for Bladder Cancer Surgery Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Bladder Cancer Surgery Clinical Trial page.

Latest updates to the Pembrolizumab for Bladder Cancer Surgery Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision label, v3.6.6, is now shown on the page. This indicates a backend or template update rather than a change to the study data or user-facing content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now shows a new system revision label (v3.6.4), replacing the previous revision (v3.6.3), indicating a software update to the site’s interface without changing study information.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a minor version update to the page metadata.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing Revision: v3.6.0. This indicates a system update deployed to the page for maintenance or bug fixes.SummaryDifference0.1%

- Check90 days agoChange DetectedAdded a recruitment status note stating the study is no longer looking for participants. New help/navigation items were introduced, including How to Read a Study Record, Common Questions, and How to Join a Study.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab for Bladder Cancer Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Bladder Cancer Surgery Clinical Trial page.